Cerebras Systems Stock Drops Well Below Offering Price Despite Vast Order Backlog
Sunnyvale, Friday, 13 November 2026.
Despite a massive $26.1 billion order backlog, Cerebras shares fell 47% below their IPO price as investors weighed serious delivery delays to key customer OpenAI against steep initial valuations.
Record Revenue Meets Investor Skepticism
On November 12, 2026, Cerebras Systems (NASDAQ: CBRS) reported record third-quarter revenue of $230.9 million, a 70% year-over-year increase, alongside a backlog of $26.1 billion [1][2]. Despite these strong operational metrics, shares of the AI hardware manufacturer closed at $97.75, representing a decline of -47.162% from its $185 IPO price in May 2026 [1]. The disconnect between financial performance and market valuation reflects growing investor unease over delivery timelines for critical AI infrastructure projects. Cerebras’s core gross margin stood at 41.0% for Q3, yet the company reported a GAAP net loss of $161.2 million, underscoring the capital-intensive nature of scaling AI hardware production [2].
Valuation Red Flags and Customer Concentration Risks
Cerebras Systems debuted on NASDAQ at a fully diluted valuation of $56.4 billion, a multiple of 111 times its projected 2025 revenue of $510 million [1]. By comparison, the company’s market capitalization had plummeted to approximately $22.25 billion by November 11, 2026, less than half its post-IPO peak [3]. Investor scrutiny has intensified due to high customer concentration, with two clients accounting for 72% of Q3 revenue, including a significant portion tied to OpenAI [1][2]. Compounding these risks are reported delays in delivering computing capacity to OpenAI, which could trigger financial penalties or partial contract terminations, further eroding confidence in execution capabilities [1].
Operational Execution Challenges Overshadow Growth
While Cerebras’s technology remains at the forefront of AI compute speed, operational hurdles have overshadowed its growth narrative. The company’s management has acknowledged delays in hardware deliveries, particularly to OpenAI, which contributed to a $26.1 billion backlog as of September 2026 [1][2]. Critics have also questioned the durability of Cerebras’s wafer-scale processors, with a short-seller report in late October 2025 prompting a rebuttal from the company, which stated that fewer than 0.5% of deployed CS-3 wafers had been decommissioned since 2024 [alert! ‘Cerebras did not provide granular data on wafer failures across all product lines’][4]. The stock’s volatility has been exacerbated by staggered share lockups, with 19.4 million shares becoming eligible for sale on September 30, 2026, coinciding with an 8.9% stock decline [1].
Market Sentiment and Future Outlook
The broader semiconductor sector has also weighed on Cerebras Systems, with pressure following reports of potential leadership changes at Nvidia (NVDA) in November 2026 [3]. Despite these challenges, Cerebras has secured 700 gross megawatts of data-center capacity for delivery by the end of 2027, signaling long-term commitments from hyperscalers [1][2]. Management has forecasted Q4 2026 core revenue of $310–330 million, a potential rebound from Q3’s $230.9 million, though core operating margins are expected to remain in negative territory at −1% to +1% [1][2]. Analysts at Morgan Stanley, UBS, and Wedbush lowered their price targets on Cerebras in the days leading up to the Q3 earnings report, reflecting a cautious outlook for the AI infrastructure sector [3][5].